Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial.
. J Virol. 2021 Sep 22:JVI0131321. doi: 10.1128/JVI.01313-21. Online ahead of print. J Virol. 2021. PMID: 34549975. Nature. 2021 Sep 13. doi: 10.1038/s41586-021-03995-1. Online ahead of print. Nature. 2021. PMID: 34517409.
Efficacy and safety of current medications for treating severe and non-severe COVID-19 patients: an updated network meta-analysis of randomized placebo-controlled trials.